Worldwide, cardiovascular diseases are estimated to be the leading cause of death and disability. Estimation of cardiovascular risk has become the cornerstone of cardiovascular diseases' prevention. Abnormalities in lipoprotein metabolism are one of the key factors but there is almost unanimous agreement among epidemiologists and clinicians that coronary risk assessment based exclusively on low density lipoprotein (LDL) is not optimal particularly in individuals at intermediate risk.
(2017). Apolipoprotein B/A-I Ratio in Diabetic Patients with Acute Coronary Syndrome - Importance and PredictiveValue. Cardiovascular Research Prove Journal, 1(1), -. doi: 10.21608/cvrepj.2017.352421
MLA
. "Apolipoprotein B/A-I Ratio in Diabetic Patients with Acute Coronary Syndrome - Importance and PredictiveValue", Cardiovascular Research Prove Journal, 1, 1, 2017, -. doi: 10.21608/cvrepj.2017.352421
HARVARD
(2017). 'Apolipoprotein B/A-I Ratio in Diabetic Patients with Acute Coronary Syndrome - Importance and PredictiveValue', Cardiovascular Research Prove Journal, 1(1), pp. -. doi: 10.21608/cvrepj.2017.352421
VANCOUVER
Apolipoprotein B/A-I Ratio in Diabetic Patients with Acute Coronary Syndrome - Importance and PredictiveValue. Cardiovascular Research Prove Journal, 2017; 1(1): -. doi: 10.21608/cvrepj.2017.352421
)
View on SCiNiTO